Novo Holdings A/S Long-Term Concentrated

Location: Hellerup, Denmark

CIK: 0001388325 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $1.126B (99.5% shares, 0.5% debt)

Holdings (17)

VTI VANGUARD INDEX FDS 21.3%

Value $240M Shares 2,155,100 Est. Cost $57.39 Unrealized —

INGN INOGEN INC 18.9%

Value $213M Shares 3,549,320 Est. Cost $17.78 Unrealized +213.4%

— OPHTHOTECH CORP 14.8%

Value $167M Shares 3,610,487 Est. Cost $32.35 Unrealized —

— COLUCID PHARMACEUTICALS INC 10.7%

Value $120M Shares 3,156,563 Est. Cost $9.83 Unrealized —

VGK VANGUARD INTL EQUITY INDEX F 9.1%

Value $102M Shares 2,101,000 Est. Cost $45.01 Unrealized —

— REATA PHARMACEUTICALS INC 7.9%

Value $88.77M Shares 3,367,763 Est. Cost $19.75 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 4.7%

Value $53.04M Shares 3,224,046 Est. Cost $14.33 Unrealized +0.6%

— ACCELERON PHARMA INC 2.9%

Value $32.71M Shares 903,833 Est. Cost $28.86 Unrealized —

— SPECTRANETICS CORP 2.6%

Value $29M Shares 1,155,722 Est. Cost $18.07 Unrealized —

— MERUS N V 2.1%

Value $23.62M Shares 1,410,417 Est. Cost $7.99 Unrealized —

— FLEXION THERAPEUTICS INC 1.9%

Value $21.45M Shares 1,097,718 Est. Cost $15.58 Unrealized —

— INVUITY INC 1.6%

Value $17.64M Shares 1,285,448 Est. Cost $9.68 Unrealized —

— NABRIVA THERAPEUTICS AG 0.7%

Value $7.872M Shares 1,116,660 Est. Cost $9.04 Unrealized —

— WRIGHT MED GROUP N V 0.5%

Value $6.055M Shares 4,622,032 Est. Cost $1.25 Unrealized —

— HTG MOLECULAR DIAGNOSTICS INC 0.3%

Value $2.906M Shares 1,280,185 Est. Cost $11.15 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.1%

Value $1.033M Shares 127,563 Est. Cost $14.68 Unrealized -47.4%

OPK OPKO HEALTH INC 0.0%

Value $3,000 Shares 259 Est. Cost $9.96 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	2,155,100	$240M	21.3%	$57.39	—	TOTAL STK MKT	922908769
INGN	INOGEN INC	3,549,320	$213M	18.9%	$17.78	+213.4%	COM	45780L104
—	OPHTHOTECH CORP	3,610,487	$167M	14.8%	$32.35	—	COM	683745103
—	COLUCID PHARMACEUTICALS INC	3,156,563	$120M	10.7%	$9.83	—	COM	19716T101
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$102M	9.1%	$45.01	—	FTSE EUROPE ETF	922042874
—	REATA PHARMACEUTICALS INC	3,367,763	$88.77M	7.9%	$19.75	—	CL A	75615P103
CRVS	CORVUS PHARMACEUTICALS INC	3,224,046	$53.04M	4.7%	$14.33	+0.6%	COM	221015100
—	ACCELERON PHARMA INC	903,833	$32.71M	2.9%	$28.86	—	COM	00434H108
—	SPECTRANETICS CORP	1,155,722	$29M	2.6%	$18.07	—	COM	84760C107
—	MERUS N V	1,410,417	$23.62M	2.1%	$7.99	—	COM	N5749R100
—	FLEXION THERAPEUTICS INC	1,097,718	$21.45M	1.9%	$15.58	—	COM	33938J106
—	INVUITY INC	1,285,448	$17.64M	1.6%	$9.68	—	COM	46187J205
—	NABRIVA THERAPEUTICS AG	1,116,660	$7.872M	0.7%	$9.04	—	COM	62957M104
—	WRIGHT MED GROUP N V	4,622,032	$6.055M	0.5%	$1.25	—	RIGHT 03/01/2019	N96617126
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$2.906M	0.3%	$11.15	—	COM	40434H104
XENE	XENON PHARMACEUTICALS INC	127,563	$1.033M	0.1%	$14.68	-47.4%	COM	98420N105
OPK	OPKO HEALTH INC	259	$3,000	0.0%	$9.96	0.0%	COM	68375N103